↓ Skip to main content

A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501

Overview of attention for article published in Advances in Therapy, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
76 Mendeley
Title
A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
Published in
Advances in Therapy, June 2019
DOI 10.1007/s12325-019-00979-6
Pubmed ID
Authors

Richard Markus, Helen J. McBride, Monica Ramchandani, Vincent Chow, Jennifer Liu, Dan Mytych, Gary Fanjiang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 76 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 17%
Student > Master 9 12%
Other 8 11%
Student > Bachelor 6 8%
Student > Ph. D. Student 6 8%
Other 11 14%
Unknown 23 30%
Readers by discipline Count As %
Medicine and Dentistry 18 24%
Pharmacology, Toxicology and Pharmaceutical Science 13 17%
Biochemistry, Genetics and Molecular Biology 4 5%
Computer Science 4 5%
Nursing and Health Professions 3 4%
Other 5 7%
Unknown 29 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2019.
All research outputs
#15,575,425
of 23,150,406 outputs
Outputs from Advances in Therapy
#1,334
of 2,388 outputs
Outputs of similar age
#217,337
of 353,445 outputs
Outputs of similar age from Advances in Therapy
#33
of 55 outputs
Altmetric has tracked 23,150,406 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,388 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,445 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.